Skip to main content
. 2017 Mar 20;71(3-4):e12901. doi: 10.1111/ijcp.12901

Table 6.

BSSM policy statements on testosterone deficiency

BSSM policy statements on testosterone deficiency
1. Testosterone deficiency is a well‐established, significant medical condition
2. Testosterone deficiency has well‐established symptoms
3. Testosterone therapy for men with testosterone deficiency is effective, rational and evidence based
4. There is no scientific basis for withholding testosterone therapy from men on the basis of age
5. Testosterone deficiency is associated with increased cardiovascular and all‐cause mortality
6. The evidence does not support an increased cardiovascular risk associated with testosterone therapy
7. There is no evidence that supports any increase in the risk of cancer of the prostate with testosterone replacement therapy
8. A major research initiative to explore the benefits of testosterone therapy in cardiometabolic disease is overdue